Elastic aortic properties in hypertrophic cardiomyopathy: a single center echocardiographic evaluation

E Vizzardi1, E Sciatti, I Bonadei

  • 1Section of Cardiovascular Diseases, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Study of Brescia, Brescia, Italy. edoardo.sc@tin.it.

Insights

Hypertrophic cardiomyopathy (HCM) patients have a larger aorta and stiffer aortic elastic properties than healthy individuals. These findings may aid in understanding treatment response and prognosis in HCM.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Imaging

Background:

  • Previous research indicates impaired aortic elastic properties in hypertrophic cardiomyopathy (HCM) patients.
  • Data on aortic dimensions in HCM patients remain inconsistent.
  • Tissue Doppler imaging (TDI) and tissue strain offer potential insights into aortic alterations.

Purpose of the Study:

  • To investigate aortic dimensions and elastic properties in HCM patients.
  • To evaluate the role of tissue Doppler imaging (TDI) and tissue strain in assessing aortic alterations in HCM.
  • To compare aortic characteristics between HCM patients and healthy controls.

Main Methods:

  • Transthoracic echocardiography was performed on 25 HCM patients and 25 age- and sex-matched healthy volunteers.
  • Aortic dimensions were measured at four distinct levels (Valsalva sinuses, sinotubular junction, tubular tract, aortic arch).
  • Aortic elastic properties (distensibility, stiffness, M-mode strain, tissue strain) and TDI aortic wall velocities (S', E', A') were assessed.

Main Results:

  • Significant differences in aortic dimensions were observed at the sinotubular junction and aortic arch.
  • HCM patients exhibited significantly higher aortic stiffness compared to controls.
  • TDI waves (S', E', A') were significantly greater in HCM patients, indicating altered aortic wall dynamics.

Conclusions:

  • HCM patients demonstrate larger aortic dimensions and altered aortic elastic properties compared to healthy individuals.
  • These findings highlight potential biomarkers for assessing HCM progression and treatment efficacy.
  • Further research may elucidate the prognostic implications of these aortic changes in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.0K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
887
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
939
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.5K